Conference · Suntec City, Singapore
Immunogenicity for Biopharmaceuticals & Biosimilars Asia
Biotechnology · Life Sciences · Biochemistry
Key numbers
- Editions on record
- 1first in 2012
About Immunogenicity for Biopharmaceuticals & Biosimilars Asia
Informa Life Sciences has over a decade-long experience in hosting Immunogenicity conferences in the US and Europe and is pleased to present the inaugural Immunogenicity for Biopharmaceuticals & Biosimilars Asia 2012. The ONLY event of its kind in the region, researched with and designed for the community of scientists driving progress and innovation in immunogenicity studies in the region. Bringing you global best practices and case studies, teamed with emerging local knowledge, this event will assist you in formulating solutions to your top immunogenicity challenges.
This comprehensive programme will provide you with a detailed insight to the immunogenicity field, including the underlying causes and implications of immunogenicity, current international developments and best practices in immunogenicity risk assessment, prediction, assay development and regulatory expectations and particular considerations for immunogenicity in the Asian region.
5 Reasons to Attend Asia Immunogenicity 2012:
-The ONLY event of its kind in Asia - A ‘must attend’ event given the rapid development of the biotech industry in Asia
-The region’s first to market event highlighting strategies for immunogenicity testing and critical advice to predict and manage unwanted immunogenicity
-Immunogenicity is a major bottleneck in the discovery and development of biotherapeutics – Don’t miss this first event in Asia that will provide you with strategies to predict and manage the immunogenicity response
-Bringing together a multidisciplinary audience this event will provide strategies from preclinical through to clinical to understand, predict and minimize the risk of an immunogenic response
-Regulatory guidances for immunogenicity are unclear – Don’t miss your opportunity to hear a regulatory perspective about minimum data requirements for FDA/EU approval
Who Should Attend
A Multidiscipli
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2012 | 15–17 Oct 2012 | Grand Copthorne Waterfront Hotel Suntec City, Singapore | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Immunogenicity for Biopharmaceuticals & Biosimilars Asia?
The next dates haven't been confirmed. The last edition we have on record was 15–17 Oct 2012.
Where is it held?
The last edition we have was at Grand Copthorne Waterfront Hotel, Suntec City, Singapore.